Physician profile
Michelle M Class
NPI 1497755201
$926.73
in general payments reported to CMS, 2019-2025
19 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.74 · 2020: $124 · 2021: $125 · 2022: $207 · 2023: $138 · 2024: $118 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $165.38 | 2022-2025 | Azstarys |
| Tris Pharma INC | $93.75 | 2019-2020 | |
| Kaleo, INC. | $76.66 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $74.58 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $56.29 | 2022-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Verrica Pharmaceuticals INC. | $55.84 | 2024 | Ycanth |
| Ultragenyx Pharmaceutical INC. | $54.77 | 2022-2024 | Crysvita |
| Cranial Technologies, INC | $51.00 | 2019-2023 | Doc Band |
| Sanofi Pasteur INC. | $39.94 | 2021-2022 | |
| Genentech USA, INC. | $39.45 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $37.22 | 2023 | Flumist Quadrivalent |
| Kowa Pharmaceuticals America, INC. | $34.33 | 2025 | Zoryve |
| Phadia US INC. | $34.29 | 2019-2022 | |
| Sobi, INC | $34.01 | 2020-2023 | |
| Lnhc, INC | $18.94 | 2025 | Zelsuvmi |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.93 | 2019 | |
| Biomarin Pharmaceutical INC. | $15.77 | 2024 | Voxzogo 1.2mg |
| Qiagen, LLC | $15.73 | 2022 | |
| Galderma Laboratories, L.P. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Class listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.